Table 1. Associations of YTHDF3 expression with clinicopathological characteristics for triple-negative breast cancer patients.
Characteristics | All patients(n=224) | Low YTHDF3 (n=123) |
High YTHDF3 (n=101) |
P valuea | |||
---|---|---|---|---|---|---|---|
No. | (%) | No. | No. | ||||
Age at diagnosis(years) | 0.570 | ||||||
≤50 | 104 | 46.4 | 55 | 49 | |||
>50 | 120 | 53.6 | 68 | 52 | |||
Tumor size | 0.706 | ||||||
≤2 cm | 94 | 42.0 | 53 | 41 | |||
>2 cm | 130 | 58.0 | 70 | 60 | |||
Lymph node metastasis | 0.028 | ||||||
No | 131 | 58.5 | 80 | 51 | |||
Yes | 93 | 41.5 | 43 | 50 | |||
Tumor Grade | 0.014 | ||||||
I + II | 84 | 37.5 | 55 | 29 | |||
III | 140 | 62.5 | 68 | 72 | |||
Lymphovascular invasion | 0.121 | ||||||
No | 141 | 62.9 | 83 | 58 | |||
Yes | 83 | 37.1 | 40 | 43 |
a, the P value was calculated among all groups by the Chi-square test. YTHDF3, the YTH domain family 3.